Skip to main content
. 2017 May 23;108(6):1271–1280. doi: 10.1111/cas.13249

Figure 3.

Figure 3

Progression‐free survival of patients with diffuse large B‐cell lymphoma‐type or classical Hodgkin lymphoma (CHL)‐type methotrexate‐associated lymphoproliferative disorders (MTX‐LPD). Patients with CHL‐type MTX‐LPD required additional chemotherapy because of no response to the discontinuation of methotrexate.